Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

8 results
Display

Photodynamic Therapy for Unresectable Cholangiocarcinoma:Does It Really Increase the Survival Time?

Choi EK, Kim MH

  • KMID: 772794
  • Korean J Gastroenterol.
  • 2005 Jun;45(6):446-446.
No abstract available
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of Brugada Syndrome Following Photodynamic Therapy in a Patient with Cholangiocarcinoma

Bang DW, Hyon MS, Cho YD, Kim SK, Kwon YJ

Brugada syndrome can be unmasked by several conditions including a febrile state, marked leukocytosis, and electrolyte disturbances. Herein, we describe a 62-year-old man with cholangiocarcinoma in the first reported case...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Photodynamic Therapy for Hilar Cholangiocarcinoma

Cheon YK

The prognosis for hilar cholangiocarcinoma is limited by tumor spread along the biliary tree leading to refractory obstructive cholestasis, cholangitis, and liver failure. Palliation with biliary endoprostheses results in median...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Outcome of Photodynamic Therapy with Systemic Chemotherapy Compared to Photodynamic Therapy Alone in Patients with Advanced Hilar Cholangiocarcinoma

Hong MJ, Cheon YK, Lee EJ, Lee TY, Shim CS

  • KMID: 1774567
  • Gut Liver.
  • 2014 May;8(3):318-323.
BACKGROUND/AIMS: Patients with cholangiocarcinoma usually present at an advanced stage, and more than 50% of cases are not resectable at the time of diagnosis. Recently, photodynamic therapy (PDT) has been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High-Dose Fentanyl Patch for Cancer Pain of a Patient with Cholangiocarcinoma

Kim JH, Kim M, Sung CW, Kim HS, Jang HJ, Shin YC, Jung JY

We describe here a patient who obtained a good analgesic effect with high-dose fentanyl patches for controlling cancer pain. A 52-year-old man was referred to our hospital because of severe...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Wentrup R, Winkelmann N, Mitroshkin A, Prager M, Voderholzer W, Schachschal G, Jürgensen C, Büning C

BACKGROUND/AIMS: Standard treatments are not available for hilar nonresectable cholangiocarcinoma (NCC). It is unknown whether combination therapy of photodynamic therapy (PDT) plus systemic chemotherapy is superior to PDT alone. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model

Lee ES, Jeong MS, Singh R, Jung J, Yoon H, Min JK, Kim KH, Hong HJ

Intrahepatic cholangiocarcinoma (ICC), a malignant tumor derived from the intrahepatic bile duct epithelium, has a poor prognosis and is refractory to conventional chemotherapy and radiation therapy. Thus, there is an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs

Puthdee N, Vaeteewoottacharn K, Seubwai W, Wonkchalee O, Kaewkong W, Juasook A, Pinlaor S, Pairojkul , Wongkham C, Okada S, Boonmars T, Wongkham S

Opisthorchis viverrini (O. viverrini) is a well-known causative agent of cholangiocarcinoma (CCA) in humans. CCA is very resistant to chemotherapy and is frequently fatal. To understand the pathogenesis of CCA...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr